Moreover, CD155 additionally correlated with mediators related to myeloid/stromal regulation (M-CSF, PDGF-bb, TRAIL) and counter-regulatory inflammation (IL-1Ra), suggesting that CD155 levels may capture broader tumor–stroma–myeloid remodeling rather than a purely T cell-restricted program. Here, CSF1 is linked to neoplasm.